These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21999927)

  • 1. Death receptor signalling in central nervous system inflammation and demyelination.
    Mc Guire C; Beyaert R; van Loo G
    Trends Neurosci; 2011 Dec; 34(12):619-28. PubMed ID: 21999927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.
    Sessler T; Healy S; Samali A; Szegezdi E
    Pharmacol Ther; 2013 Nov; 140(2):186-99. PubMed ID: 23845861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
    Raine CS; Bonetti B; Cannella B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas(t) track to apoptosis in MS: TNF receptors may suppress or potentiate CNS demyelination.
    Segal BM; Cross AH
    Neurology; 2000 Oct; 55(7):906-7. PubMed ID: 11061241
    [No Abstract]   [Full Text] [Related]  

  • 5. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.
    Akassoglou K; Bauer J; Kassiotis G; Pasparakis M; Lassmann H; Kollias G; Probert L
    Am J Pathol; 1998 Sep; 153(3):801-13. PubMed ID: 9736029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
    Mc Guire C; Prinz M; Beyaert R; van Loo G
    Trends Mol Med; 2013 Oct; 19(10):604-13. PubMed ID: 24007818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death receptors: targets for cancer therapy.
    Mahmood Z; Shukla Y
    Exp Cell Res; 2010 Apr; 316(6):887-99. PubMed ID: 20026107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The good and the bad of neuroinflammation in multiple sclerosis.
    Naegele M; Martin R
    Handb Clin Neurol; 2014; 122():59-87. PubMed ID: 24507513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-based therapeutic approaches targeting death receptors.
    French LE; Tschopp J
    Cell Death Differ; 2003 Jan; 10(1):117-23. PubMed ID: 12655300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the extrinsic apoptotic pathway by TNF-alpha in human salivary gland (HSG) cells in vitro, suggests a role for the TNF receptor (TNF-R) and intercellular adhesion molecule-1 (ICAM-1) in Sjögren's syndrome-associated autoimmune sialadenitis.
    Wang Y; Shnyra A; Africa C; Warholic C; McArthur C
    Arch Oral Biol; 2009 Nov; 54(11):986-96. PubMed ID: 19716548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Death receptor signaling and autoimmunity.
    Siegel RM; Muppidi J; Roberts M; Porter M; Wu Z
    Immunol Res; 2003; 27(2-3):499-512. PubMed ID: 12857993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease.
    Probert L; Eugster HP; Akassoglou K; Bauer J; Frei K; Lassmann H; Fontana A
    Brain; 2000 Oct; 123 ( Pt 10)():2005-19. PubMed ID: 11004118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic models for CNS inflammation.
    Owens T; Wekerle H; Antel J
    Nat Med; 2001 Feb; 7(2):161-6. PubMed ID: 11175845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death receptor-mediated liver injury.
    Akazawa Y; Gores GJ
    Semin Liver Dis; 2007 Nov; 27(4):327-38. PubMed ID: 17979070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways.
    Mountz JD; Zhou T; Su X; Cheng J; Pierson M; Bluethmann H; Edwards CK
    Behring Inst Mitt; 1996 Oct; (97):200-19. PubMed ID: 8950477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death ligands and autoimmune demyelination.
    Aktas O; Prozorovski T; Zipp F
    Neuroscientist; 2006 Aug; 12(4):305-16. PubMed ID: 16840707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
    Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
    J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.
    Taoufik E; Tseveleki V; Chu SY; Tselios T; Karin M; Lassmann H; Szymkowski DE; Probert L
    Brain; 2011 Sep; 134(Pt 9):2722-35. PubMed ID: 21908876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.